You are here

HilleVax

Takeda spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants

Fierce Biotech

Tue, 07/9/24 - 11:21 am

clinical trials

HilleVax’s IPO hauls in $200M for clinical test of VLP norovirus vaccine from Takeda

MedCity News

Mon, 05/2/22 - 11:46 am

Takeda shunts jewel of Shire takeover to new spinoff Oak Hill

Fierce Biotech

Tue, 02/1/22 - 10:33 am

HilleVax Rakes in $135 Million to Rapidly Progress Norovirus Vaccine

BioSpace

Wed, 09/8/21 - 11:17 pm

Takeda allies with Frazier to spin out late-phase norovirus vaccine

Fierce Biotech

Fri, 07/30/21 - 11:09 am

Frazier Healthcare